Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 17.78 points (-0.1%) at 16,992 as of Monday, Oct. 6, 2014, 4:20 PM ET. The NYSE advances/declines ratio sits at 1,538 issues advancing vs. 1,555 declining with 128 unchanged.

The Drugs industry as a whole closed the day down 1.8% versus the S&P 500, which was down 0.2%. Top gainers within the Drugs industry included Prima Biomed ( PBMD), up 3.9%, EntreMed ( ENMD), up 2.3%, Sophiris Bio ( SPHS), up 3.7%, Fate Therapeutics ( FATE), up 2.1% and Can Fite Biofarma ( CANF), up 1.7%.

TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today:

Fate Therapeutics ( FATE) is one of the companies that pushed the Drugs industry higher today. Fate Therapeutics was up $0.11 (2.1%) to $5.30 on average volume. Throughout the day, 22,683 shares of Fate Therapeutics exchanged hands as compared to its average daily volume of 17,400 shares. The stock ranged in a price between $5.00-$5.30 after having opened the day at $5.07 as compared to the previous trading day's close of $5.19.

Fate Therapeutics has a market cap of $104.5 million and is part of the health care sector. Shares are down 17.4% year-to-date as of the close of trading on Friday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

At the close, Sophiris Bio ( SPHS) was up $0.10 (3.7%) to $2.96 on light volume. Throughout the day, 3,357 shares of Sophiris Bio exchanged hands as compared to its average daily volume of 27,300 shares. The stock ranged in a price between $2.85-$2.96 after having opened the day at $2.85 as compared to the previous trading day's close of $2.86.

Sophiris Bio has a market cap of $50.0 million and is part of the health care sector. Shares are down 22.8% year-to-date as of the close of trading on Friday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

EntreMed ( ENMD) was another company that pushed the Drugs industry higher today. EntreMed was up $0.04 (2.3%) to $1.76 on light volume. Throughout the day, 7,451 shares of EntreMed exchanged hands as compared to its average daily volume of 20,800 shares. The stock ranged in a price between $1.70-$1.79 after having opened the day at $1.70 as compared to the previous trading day's close of $1.72.

EntreMed has a market cap of $47.1 million and is part of the health care sector. Shares are up 2.9% year-to-date as of the close of trading on Friday.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.